Linkage to Care for Persons with Hep C Infection
Implementation of Low Cost Solutions to Help Facilitate Linkage to Care for Persons with Hepatitis C Virus Infection
2 other identifiers
interventional
80
1 country
1
Brief Summary
Hepatitis C Virus (HCV) infection is an ongoing challenge in the United States, with an estimated 2.4 million individuals living with HCV in 2016. According to the Virginia Department of Health, over 11,500 people were living with HCV infection in 2017 with a rate of 170 reported cases/100,000 adults. This same year, the situation was even more dire in Roanoke City which had a rate of 524/100,000 adults. Treatment with antiviral medication is curative and well tolerated. However, gaps remain in the ability of the health system to engage the most vulnerable patients to start and complete treatment. People with HCV infection usually are unaware of the infection, which allows the disease to progress to liver damage, liver cancer and death if left untreated.At each stage of the screening, testing, and treatment process, there is significant patient loss to follow-up. Drop-off most commonly occurs between diagnosis and the first visit to a treating provider. Key barriers to successful engagement include: 1) communication issues, such as lack of phone or limited phone access; 2) lack of transportation; 3) significant social issues such as poverty; 4) substance use disorder; and 5) a limited understanding of the consequences of untreated HCV infection. In this mixed-method design, the investigators propose a pilot study that will provide education and resources, such as vouchers for phone, transportation, and meals, to the most vulnerable patients that will facilitate engagement in treatment as additional factors that may influence dropout rates are evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2022
CompletedFirst Posted
Study publicly available on registry
May 31, 2022
CompletedStudy Start
First participant enrolled
July 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 4, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 4, 2025
CompletedMarch 4, 2025
February 1, 2025
2.6 years
May 23, 2022
February 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Attendance at first appointment
Attendance at first appointment for HCV treatment will be compared between the control and intervention arms
Through study completion, an average of 6 months
Other Outcomes (1)
Semi-structured qualitative interviews
Interviews will be conducted through study completion, an average of 6 months for the selected participants and care providers. Interviews will be collected throughout the study.
Study Arms (2)
Peer specialist and Vouchers
EXPERIMENTALIntervention arm
Standard of care
NO INTERVENTIONInterventions
this participants will receive vouchers from PS
Eligibility Criteria
You may qualify if:
- years or older, positive Hepatitis C antibody test,
- elevated Hepatitis C RNA
- history of substance use disorder
You may not qualify if:
- under 18 years old,
- history of treatment of Hepatitis C infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Carilion Clinic
Roanoke, Virginia, 24014, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 23, 2022
First Posted
May 31, 2022
Study Start
July 12, 2022
Primary Completion
February 4, 2025
Study Completion
February 4, 2025
Last Updated
March 4, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share